[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Bitar et al., 2012 - Google Patents

Silica-based nanoparticles for biomedical applications

Bitar et al., 2012

View PDF
Document ID
13262006653192470168
Author
Bitar A
Ahmad N
Fessi H
Elaissari A
Publication year
Publication venue
Drug discovery today

External Links

Snippet

In this short review we highlight novel uses of silica-based nanoparticles (NPs) in the biomedical sector. Silica NPs are widely used in nanotechnology because they are easy to prepare and inexpensive to produce. Their specific surface characteristics, porosity and …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48869—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being a micro- or nano-capsule or a micro/nano-bubble, i.e. a hollow or gas micro- or nano-particle or sphere, a gas-filled micro- or nano-particle for use in therapy
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANO-TECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANO-STRUCTURES; MEASUREMENT OR ANALYSIS OF NANO-STRUCTURES; MANUFACTURE OR TREATMENT OF NANO-STRUCTURES
    • B82Y30/00—Nano-technology for materials or surface science, e.g. nano-composites

Similar Documents

Publication Publication Date Title
Bitar et al. Silica-based nanoparticles for biomedical applications
Shang et al. Recent advances in synthesizing metal nanocluster-based nanocomposites for application in sensing, imaging and catalysis
Materón et al. Magnetic nanoparticles in biomedical applications: A review
Dolatabadi et al. Applications of diatoms and silica nanotechnology in biosensing, drug and gene delivery, and formation of complex metal nanostructures
Lin et al. Well-ordered mesoporous silica nanoparticles as cell markers
Kumar et al. Covalently dye-linked, surface-controlled, and bioconjugated organically modified silica nanoparticles as targeted probes for optical imaging
Klichko et al. Mesostructured silica for optical functionality, nanomachines, and drug delivery
Knopp et al. Bioanalytical applications of biomolecule-functionalized nanometer-sized doped silica particles
Iriarte‑Mesa et al. Gold, silver and iron oxide nanoparticles: synthesis and bionanoconjugation strategies aiming to electrochemical applications
Deng et al. Aptamer-mediated up-conversion core/MOF shell nanocomposites for targeted drug delivery and cell imaging
Niemeyer Nanoparticles, proteins, and nucleic acids: biotechnology meets materials science
Shi et al. Functionalized halloysite nanotube-based carrier for intracellular delivery of antisense oligonucleotides
Schärtl Current directions in core–shell nanoparticle design
Corr et al. Multifunctional magnetic-fluorescent nanocomposites for biomedical applications
Wang et al. The synthesis and bio-applications of magnetic and fluorescent bifunctional composite nanoparticles
Liu et al. Targeted intracellular controlled drug delivery and tumor therapy through in situ forming Ag nanogates on mesoporous silica nanocontainers
Gao et al. Iron oxide nanozyme: A multifunctional enzyme mimetics for biomedical application
Ji et al. Protein‐mimicking nanoparticles in biosystems
Nasirzadeh et al. Inorganic nanomaterials: A brief overview of the applications and developments in sensing and drug delivery
Liu et al. Silica nanoparticles as promising drug/gene delivery carriers and fluorescent nano-probes: recent advances
Wang et al. Preparation of microgels with ultrahigh payload of various hydrophilic and hydrophobic inorganic nanoparticle composites up to 92 wt%
Vaz et al. Synthesis and characterization of biocatalytic γ-Fe2O3@ SiO2 particles as recoverable bioreactors
Ahmad et al. Unique properties of surface-functionalized nanoparticles for bio-application: functionalization mechanisms and importance in application. Nanomaterials. 2022; 12 (8): 1333
Dowaidar et al. Improvement of transfection with pepfects using organic and inorganic materials
Kang et al. In-vitro cytotoxicity assessment of carbon-nanodot-conjugated Fe-aminoclay (CD-FeAC) and its bio-imaging applications